In a study of metastatic neuroendocrine tumors in the lungs, thyroids, and prostates of transgenic mice, researchers at the Washington University School of Medicine in St. Louis have linked a high level of the neurotransmitter GABA with a poor prognosis for human patients with neuroendocrine cancers, a finding that may lead to diagnostics to guide treatment.

The study will appear in the July 12 issue of the Proceedings of the National Academy of Sciences, and it is currently available in the online version of the journal.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.